Technical Analysis for CTLT - Catalent, Inc.

Grade Last Price % Change Price Change
grade B 42.67 0.23% 0.10
CTLT closed up 0.23 percent on Tuesday, March 19, 2019, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CTLT trend table...

Date Alert Name Type % Chg
Mar 19 20 DMA Resistance Bearish 0.00%
Mar 19 Bollinger Band Squeeze Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 19 Doji - Bearish? Reversal 0.00%
Mar 19 Up 3 Days in a Row Strength 0.00%
Mar 18 Bollinger Band Squeeze Range Contraction 0.23%
Mar 15 Bollinger Band Squeeze Range Contraction 1.11%
Mar 14 Bollinger Band Squeeze Range Contraction 1.86%
Mar 13 Bollinger Band Squeeze Range Contraction 1.47%
Mar 12 1,2,3 Pullback Bullish Bullish Swing Setup 2.08%

Older signals for CTLT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Biotechnology Biopharmaceutical Manufacturing Life Sciences Pharmaceutical Industry Pharmacy Pharmacology Dosage Forms Biologic Products Specialty Drugs In The United States Consumer Health Products Inventory Management Services
Is CTLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 46.43
52 Week Low 29.23
Average Volume 847,902
200-Day Moving Average 40.0125
50-Day Moving Average 39.2622
20-Day Moving Average 42.7635
10-Day Moving Average 42.243
Average True Range 0.817
ADX 33.81
+DI 24.941
-DI 16.6474
Chandelier Exit (Long, 3 ATRs ) 41.689
Chandelier Exit (Short, 3 ATRs ) 43.691
Upper Bollinger Band 44.0609
Lower Bollinger Band 41.4661
Percent B (%b) 0.46
BandWidth 6.067791
MACD Line 0.7113
MACD Signal Line 1.0119
MACD Histogram -0.3005
Fundamentals Value
Market Cap 5.35 Billion
Num Shares 125 Million
EPS 0.87
Price-to-Earnings (P/E) Ratio 49.05
Price-to-Sales 2.57
Price-to-Book 7.36
PEG Ratio 3.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.33
Resistance 3 (R3) 43.33 43.10 43.22
Resistance 2 (R2) 43.10 42.94 43.11 43.18
Resistance 1 (R1) 42.89 42.83 42.78 42.89 43.15
Pivot Point 42.66 42.66 42.61 42.67 42.66
Support 1 (S1) 42.45 42.50 42.34 42.45 42.19
Support 2 (S2) 42.22 42.39 42.23 42.16
Support 3 (S3) 42.01 42.22 42.12
Support 4 (S4) 42.01